Evidence map›Paper›PMID 35202153›Full record

ReviewToxins2022

Management of Double Sensitization to Vespids in Europe.

Berta Ruiz-Leon, Pilar Serrano, Carmen Vidal, Carmen Moreno-Aguilar

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Homology Analysis ofToxins · 2026
    Article
  2. Observational
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Proteomics ofToxins · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Berta Ruiz-LeonAllergy Section of University Hospital Reina Sofia-IMIBIC, ARADyAL Network, National Institute of Health Carlos III, 14005 Cordoba, Spain.
Pilar SerranoAllergy Section of University Hospital Reina Sofia-IMIBIC, ARADyAL Network, National Institute of Health Carlos III, 14005 Cordoba, Spain.
Carmen VidalAllergy Department of Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-2844-2754
Carmen Moreno-AguilarAllergy Section of University Hospital Reina Sofia-IMIBIC, ARADyAL Network, National Institute of Health Carlos III, 14005 Cordoba, Spain.
Instituto de Salud Carlos III · ESComplejo Hospitalario Universitario de Santiago · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wasp allergy with a diagnostic profile of double sensitizations to vespid venom is a frequent clinical problem in areas where different genera of wasps are present. Identification of the insect responsible for serious reactions poses a diagnostic challenge as the only effective treatment to date is immunotherapy based on the specific venom. In southern Europe, the double sensitization to

Indexed as

ImmunotherapyAllergensAnimalsCross ReactionsHumansHypersensitivityWaspsWasp VenomsAllergensWasp Venomsallergenscross-reactivitydouble sensitization to vespidsPolistesvenom immunotherapyVespula

Identifiers

PMID35202153
PMCPMC8880449
OpenAlexW4211236545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.